Healthy volunteers needed to compare generic vs. brand cabergoline
NCT ID NCT07008417
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study checks if a new version of cabergoline tablets works the same as the standard version in 72 healthy Chinese adults aged 18-45. Participants take one dose of each version under fasting or after a meal, with blood tests to measure drug levels. The goal is to confirm bioequivalence, not to treat any condition.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HYPERPROLACTINEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Zhejiang Xiaoshan Hospital
Hangzhou, Zhejiang, 200233, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.